142 related articles for article (PubMed ID: 9764655)
1. Aborted leiomyosarcoma after treatment with leuprolide acetate.
Mesia AF; Williams FS; Yan Z; Mittal K
Obstet Gynecol; 1998 Oct; 92(4 Pt 2):664-6. PubMed ID: 9764655
[TBL] [Abstract][Full Text] [Related]
2. Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri.
Scialli AR; Levi AJ
Fertil Steril; 2000 Sep; 74(3):540-6. PubMed ID: 10973652
[TBL] [Abstract][Full Text] [Related]
3. Effects of leuprolide acetate on treatment of leiomyomata--clues to mechanisms of action.
Demopoulos RI; Mesia AF
Adv Anat Pathol; 1998 Mar; 5(2):129-36. PubMed ID: 9868519
[No Abstract] [Full Text] [Related]
4. Histology of leiomyomata in patients treated with leuprolide acetate.
Demopoulos RI; Jones KY; Mittal KR; Vamvakas EC
Int J Gynecol Pathol; 1997 Apr; 16(2):131-7. PubMed ID: 9100066
[TBL] [Abstract][Full Text] [Related]
5. Exacerbation of lupus nephritis in association with leuprorelin injection for uterine leiomyoma.
Metcalfe W; Boulton-Jones JM
Nephrol Dial Transplant; 1997 Aug; 12(8):1699-700. PubMed ID: 9269652
[No Abstract] [Full Text] [Related]
6. Transient shrinkage of a uterine leiomyosarcoma treated with GnRH agonist for a presumed uterine leiomyoma: comparison of magnetic resonance imaging finding before and during GnRH agonist treatment.
Kawamura N; Iwanaga N; Hada S; Maeda K; Sumi T; Ishiko O; Ogita S
Oncol Rep; 2001; 8(6):1255-7. PubMed ID: 11605044
[TBL] [Abstract][Full Text] [Related]
7. Ulipristal acetate versus leuprolide acetate for uterine fibroids.
Donnez J; Tomaszewski J; Vázquez F; Bouchard P; Lemieszczuk B; Baró F; Nouri K; Selvaggi L; Sodowski K; Bestel E; Terrill P; Osterloh I; Loumaye E;
N Engl J Med; 2012 Feb; 366(5):421-32. PubMed ID: 22296076
[TBL] [Abstract][Full Text] [Related]
8. Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: a case report and literature review.
Milman D; Zalel Y; Biran H; Open M; Caspi B; Hagay Z; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):237-40. PubMed ID: 9481582
[TBL] [Abstract][Full Text] [Related]
9. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
Scialli AR; Jestila KJ
Fertil Steril; 1995 Aug; 64(2):313-20. PubMed ID: 7615109
[TBL] [Abstract][Full Text] [Related]
10. Massive ascites after leuprolide acetate administration for the treatment of leiomyomata uteri.
Lee MJ; Kazer RR
Fertil Steril; 1992 Aug; 58(2):416-8. PubMed ID: 1633912
[TBL] [Abstract][Full Text] [Related]
11. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
Jasonni VM; D'Anna R; Mancuso A; Caruso C; Corrado F; Leonardi I
Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
[TBL] [Abstract][Full Text] [Related]
12. Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata.
Deligdisch L; Hirschmann S; Altchek A
Fertil Steril; 1997 May; 67(5):837-41. PubMed ID: 9130887
[TBL] [Abstract][Full Text] [Related]
13. Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma.
Kadhel P; Smail M; Borja De Mozota D
J Gynecol Obstet Hum Reprod; 2017 Sep; 46(7):609-611. PubMed ID: 28647614
[TBL] [Abstract][Full Text] [Related]
14. Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata.
Nakayama H; Yano T; Sagara Y; Kikuchi A; Ando K; Wang Y; Watanabe M; Matsumi H; Osuga Y; Momoeda M; Taketani Y
Gynecol Endocrinol; 1999 Dec; 13(6):382-9. PubMed ID: 10685331
[TBL] [Abstract][Full Text] [Related]
15. Variable response of uterine leiomyomas after GnRH agonist therapy.
Brosens IA
Fertil Steril; 1997 Nov; 68(5):948-9. PubMed ID: 9389836
[No Abstract] [Full Text] [Related]
16. Treatment of urinary retention caused by uterine leiomyoma with a gonadotropin-releasing hormone agonist: case report and review.
Chu CM; Dabney L; Hardart A
Female Pelvic Med Reconstr Surg; 2013; 19(1):52-5. PubMed ID: 23321661
[TBL] [Abstract][Full Text] [Related]
17. [Size reduction of uterine myomas with monthly administered leuprolide acetate].
Cheviakoff S; Bocaz JA; Martínez L; Romero C
Rev Chil Obstet Ginecol; 1994; 59(6):416-20; discussion 420-1. PubMed ID: 7569160
[TBL] [Abstract][Full Text] [Related]
18. Unsuspected leiomyosarcoma: treatment with a gonadotropin-releasing hormone analogue.
Meyer WR; Mayer AR; Diamond MP; Carcangiu ML; Schwartz PE; DeCherney AH
Obstet Gynecol; 1990 Mar; 75(3 Pt 2):529-32. PubMed ID: 2106109
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of leuprolide acetate treatment on histopathology of uterine myomata.
Gutmann JN; Thornton KL; Diamond MP; Carcangiu ML
Fertil Steril; 1994 Apr; 61(4):622-6. PubMed ID: 8150102
[TBL] [Abstract][Full Text] [Related]
20. Leuprolide acetate depot for the treatment of uterine leiomyomas. Changes in bone density, uterine volume and uterine vascular resistive index.
Rivlin ME; Patel RB; Hess LW; Hess DB; Meeks GR
J Reprod Med; 1994 Sep; 39(9):663-6. PubMed ID: 7807474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
